ADAG adagene.com: Uzoq muddatli qarzning kapitalga koeffitsiyenti
Adagene onkologiya markazlari bilan hamkorlik orqali SAFEbody texnologiyasidan foydalanib, immunologik dori vositalarini ishlab chiqishni kengaytirmoqda. Uzoq muddatli qarzning kapitalga nisbati tuzilmasi kredit riski dinamikasini aks ettiradi, 0.01 esa yangi darajani belgilaydi. Biroq, sotuvlar yo'qligi sababli tashqi moliyalashtirishga bog'liqlik risklarni keltirib chiqaradi. Shu bilan birga, antitanalar sintezi uchun mo'ljallangan AI platformasi kompaniyaning global sog'liqni saqlash gigantlari orasida yuqori obro'ga ega bo'lishini ta'minlaydi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ADAG_-_Adagene_-_Long-Term-Debt-to-Capital "ADAG: Adagene Corp Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Adagene Inc (ADAG) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Adagene|ADAG - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Adagene Corp|ADAG - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Adagene Inc.|ADAG - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Adagene
Kompaniyaning dastlabki tahlili:ADAG, adagene.com
Aktivlarning operatsion kuchini baholash kapital tuzilmasini tahlil qilishdan boshlanadi. Adagene (ADAG) uchun antitanachlar platformasini litsenziyalashdan olinadigan barqaror daromadlar qarz moliyalashtirishga bo'lgan ehtiyojni minimallashtiradi. Qarzga tegishli ushbu uzoq muddatli moliyaviy barqarorlik ko'rsatkichi kapitalga nisbatan muddati bir yildan ortiq bo'lgan kreditlarning ulushini o'lchaydi. Ushbu koeffitsiyentning pasayishi to'lov qobiliyatining ortayotganini tasdiqlaydi. Biznesning joriy naqd pul inersiyasi qarz risklariga yuqori chidamlilikni kafolatlaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Vera Therapeutics Inc (VERA)|Uzoq muddatli qarzning kapitalga nisbati DNTH|Pharvaris Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN (Precigen) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|NKTR (Nektar) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati UPB|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc ZBIO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com (IMNM)|GOSS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati KalVista Pharma KALV|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Savara Inc.|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Astria Therapeutics Inc|ENGN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati rapt.com (RAPT)|JBIO: Uzoq muddatli qarzning kapitalga nisbati|aclaristx.com - Uzoq muddatli majburiyatlarning kapitalga nisbati|Kyverna Therapeutics, Inc. (KYTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TLSA - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CABA|Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati avalotx.com|Uzoq muddatli qarzning kapitalga nisbati Eledon Pharmaceuticals, Inc. ELDN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Agenus, Inc. (AGEN)|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzning kapitalga nisbati zurabio.com ZURA|Uzoq muddatli qarzning kapitalga nisbati ATYR|IMA: Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati shattucklabs.com (STTK)|Equillium (EQ) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CNTB - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Immunic Inc|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati IFRX (inflarx.de)|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc.|Adicet Bio Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati kezarlifesciences.com|SABS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Akari Therapeutics PLC|ENLV (Enlivex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati QTTB (q32bio.com)|GeoVax Labs, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|edesabiotech.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Carisma Therapeutics (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT (Bolt Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc. (HCWB)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Aptevo|AIM ImmunoTech - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|CalciMedica Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Affimed Therapeutics|Allakos Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati HOOK (hookipapharma.com)|IGMS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi iTeos Therapeutics Inc ITOS|OCEA (Ocean Bio) - Uzoq muddatli qarzning kapitalga nisbati|TCBP - Uzoq muddatli majburiyatlarning kapitalga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati